John David Yee's most recent trade in Tempest Therapeutics Inc was a trade of 25,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 4, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tempest Therapeutics Inc | John David Yee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2026 | 25,000 | 25,000 | - | - | Stock Option (right to buy) |